FDA Inspection
USpharma, Ltd., Co.USpharma, Ltd., Co. – FDA Inspection, Jun 23, 2022
Record Details
This FDA Inspection record concerns USpharma, Ltd., Co., with an inspection on June 23, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- USpharma, Ltd., Co.
- Inspection Date
- June 23, 2022
- Product Type
- Drugs
View Company Profile
ID · 0ee76a7c-aa1f-4f24-b92d-d10003c36418
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1172561
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.165(e)Test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of USpharma, Ltd., Co.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2026 | VAI | Florida District Office | Drug Quality Assurance |
| September 1, 2026 | Not classified | Florida District Office | |
| May 11, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 16, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for USpharma, Ltd., Co.
- FDA Inspection 1334262 - 2026-09-03
- FDA Inspection 1334958 - 2026-09-01
- FDA Inspection 1205546 - 2023-05-11
- FDA Inspection 1198249 - 2023-02-16
- FDA Inspection 912614 - 2015-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.